Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Takeda OncologyTakeda Oncology
VS
MENARINI GroupMENARINI Group
Takeda Oncology

Takeda Oncology

40 Landsdowne St., Cambridge, MA, 02139, US

Last Update: 28/02/2026

View Profile
764/1000Fair

Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. At Takeda, we are united by our aspiration to cure cancer. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:1,665
Subsidiaries:6
12-month incidents
0
Known data breaches
0
Attack type number
0
MENARINI Group

MENARINI Group

Via dei Sette Santi 1/3, Firenze, 50131, IT

Last Update: 12/09/2026

View Profile
Between 750 and 799
https://www.menarini.com
785/1000Fair

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,065
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Takeda Oncology

Takeda Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MENARINI Group

MENARINI Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Takeda Oncology in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MENARINI Group in 2026.

Incidents

Incident History - Takeda Oncology (X = Date, Y = Severity)

Takeda Oncology cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MENARINI Group (X = Date, Y = Severity)

MENARINI Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Takeda Oncology

Takeda Oncology

Incidents
No explicit notable incidents reported.
MENARINI Group

MENARINI Group

Incidents
No explicit notable incidents reported.

FAQ

Between Takeda Oncology company and MENARINI Group company, which one has the best AI Cybersecurity Score ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced more cyber incidents in the past ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced more cyber incidents this year ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced at least one ransomware attack ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced at least one data breach ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced at least one targeted cyberattack ?
Between Takeda Oncology company and MENARINI Group company, which one has experienced at least one vulnerability ?
Between Takeda Oncology company and MENARINI Group company, which one holds the most compliance certifications ?
Between Takeda Oncology company and MENARINI Group company, which one holds the fewest compliance certifications ?
Between Takeda Oncology company and MENARINI Group company, which one has the most subsidiaries ?
Between Takeda Oncology company and MENARINI Group company, which one has the largest number of employees ?
Between Takeda Oncology and MENARINI Group, which company holds both SOC 2 Type 1 certifications ?
Between Takeda Oncology and MENARINI Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Takeda Oncology or MENARINI Group ?
Which company is PCI DSS compliant - Takeda Oncology or MENARINI Group ?
Between Takeda Oncology and MENARINI Group, which company complies with HIPAA regulations for healthcare data ?
Between Takeda Oncology and MENARINI Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94057
SUMMARY

Exim before 4.100.1 allows SMTP smuggling in which the received message does not match any sent message, and instead depends on crafted data sent after a rejection during DATA processing.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 4)
CVSS3
Base Score: 4.0
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94056
SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, allows attackers to read certain uninitialized data from stack memory.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:N/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.2
CVE-2026-94055
SUMMARY

Exim before 4.100.1, when certain non-default TLS settings are used with GnuTLS, has a use-after-free.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94054
SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, has an out-of-bounds write.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 7)
CVSS3
Base Score: 7.0
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.2
CVE-2026-93993
SUMMARY

Mistral Vibe before 2.25.5 contains a remote code execution vulnerability in the worktree creation process that executes git hooks before trust validation. Attackers can supply a repository with a crafted post-checkout hook that executes arbitrary shell commands with the privileges of the user running Vibe.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8